![Pharmacokinetics and Pharmacodynamics of Fosfomycin and Its Activity against Extended-Spectrum-β-Lactamase-, Plasmid-Mediated AmpC-, and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model | Antimicrobial Agents and ... Pharmacokinetics and Pharmacodynamics of Fosfomycin and Its Activity against Extended-Spectrum-β-Lactamase-, Plasmid-Mediated AmpC-, and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model | Antimicrobial Agents and ...](https://journals.asm.org/cms/10.1128/AAC.02560-17/asset/8b7dfd2f-876d-4b2e-8388-344492835a85/assets/graphic/zac0061871890003.jpeg)
Pharmacokinetics and Pharmacodynamics of Fosfomycin and Its Activity against Extended-Spectrum-β-Lactamase-, Plasmid-Mediated AmpC-, and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model | Antimicrobial Agents and ...
![Frontiers | Efficacy of Fosfomycin and Its Combination With Aminoglycosides in an Experimental Sepsis Model by Carbapenemase-Producing Klebsiella pneumoniae Clinical Strains Frontiers | Efficacy of Fosfomycin and Its Combination With Aminoglycosides in an Experimental Sepsis Model by Carbapenemase-Producing Klebsiella pneumoniae Clinical Strains](https://www.frontiersin.org/files/Articles/615540/fmed-08-615540-HTML-r1/image_m/fmed-08-615540-t001.jpg)
Frontiers | Efficacy of Fosfomycin and Its Combination With Aminoglycosides in an Experimental Sepsis Model by Carbapenemase-Producing Klebsiella pneumoniae Clinical Strains
Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherich
![Fosfomycin: what was old is new again - Avent - 2018 - Internal Medicine Journal - Wiley Online Library Fosfomycin: what was old is new again - Avent - 2018 - Internal Medicine Journal - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/208240ce-03f1-413e-ac7e-852a55762751/imj14122-tbl-0001-m.jpg)
Fosfomycin: what was old is new again - Avent - 2018 - Internal Medicine Journal - Wiley Online Library
![PDF) Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation PDF) Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation](https://www.researchgate.net/publication/305275601/figure/tbl1/AS:669319352553478@1536589577134/MICs-of-non-MDR-PA-and-MDR-PA-isolates-against-tested-agents-mono-drugs-and-combination_Q320.jpg)
PDF) Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation
![Antibiotics | Free Full-Text | Evaluation of Intravenous Fosfomycin Disodium Dosing Regimens in Critically Ill Patients for Treatment of Carbapenem-Resistant Enterobacterales Infections Using Monte Carlo Simulation Antibiotics | Free Full-Text | Evaluation of Intravenous Fosfomycin Disodium Dosing Regimens in Critically Ill Patients for Treatment of Carbapenem-Resistant Enterobacterales Infections Using Monte Carlo Simulation](https://pub.mdpi-res.com/antibiotics/antibiotics-09-00615/article_deploy/html/images/antibiotics-09-00615-g001a.png?1600389486)